The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IWWM-12 2024 | Detecting clonal hematopoiesis in patients with Waldenström’s macroglobulinemia
Adam Sperling, MD, PhD, Dana Farber Cancer Institute, Boston, MA, speaks about diagnostic techniques used to identify clonal hematopoiesis in patients with Waldenström’s macroglobulinemia. He recommends the use of targeted next-generation sequencing of the peripheral blood to identify clonal mutations. This interview took place at the 12th International Workshop on Waldenström’s Macroglobulinemia (IWWM-12) in Prague, Czech Republic.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
